GPT and Cirrhosis: The WHO’s simplified criteria recommend initiating treatment based on persistently abnormal alanine transaminase (ALT) over 6–12 months, evidence of clinically defined cirrhosis, or an aspartate aminotransferase-to-platelet ratio index (APRI) > 2 [9].